The evaluation of synergistic effects of combination therapy with sulfasalazine and angiotensin-converting enzyme inhibitor in the treatment of experimental colitis in mice
Physiology and Pharmacology · 2024
DOI: 10.61186/phypha.28.2.169 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiology and Pharmacology, 2024. Verfasst von Asma Mostafapour und 8 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mostafapour, A., Asgharzadeh, F., Nazari, S. E., Eskandari, M., Naghibzadeh, N., baharara, J., Avan, A., Hassanian, S. M., & Khazaei, M. (2024). The evaluation of synergistic effects of combination therapy with sulfasalazine and angiotensin-converting enzyme inhibitor in the treatment of experimental colitis in mice. Physiology and Pharmacology. https://doi.org/10.61186/phypha.28.2.169
Vancouver
Mostafapour A, Asgharzadeh F, Nazari SE, Eskandari M, Naghibzadeh N, baharara J, et al. The evaluation of synergistic effects of combination therapy with sulfasalazine and angiotensin-converting enzyme inhibitor in the treatment of experimental colitis in mice. Physiology and Pharmacology. 2024. doi:10.61186/phypha.28.2.169
BibTeX
@article{Mostafapour2024,
author = {Mostafapour, Asma and Asgharzadeh, Fereshteh and Nazari, Seyedeh Elnaz and Eskandari, Moein and Naghibzadeh, Niloufar and baharara, Javad and Avan, Amir and Hassanian, Seyed Mahdi and Khazaei, Majid},
title = {The evaluation of synergistic effects of combination therapy with sulfasalazine and angiotensin-converting enzyme inhibitor in the treatment of experimental colitis in mice},
journal = {Physiology and Pharmacology},
year = {2024},
doi = {10.61186/phypha.28.2.169}
}
EUVIMED